FDA Adverse Event Malfunction Summary report: N

TELIGEN

MDR report key: 1851774 · Received October 4, 2010

Report

Report Number
2124215-2010-14201
Event Type
Malfunction
Date Received
October 4, 2010
Date of Event
July 9, 2010
Report Date
July 9, 2010
Manufacturer
GUIDANT CRM CLONMEL IRELAND
Product Code
LWS
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

A BOSTON SCIENTIFIC CRM TECHNICAL SERVICE CONSULTANT REVIEWED THE EVENT AND DISCUSSED THAT THERE IS NO OTHER SOLUTION BUT TO TAKE THE DEVICE OUT. DEVICES IN SAFECORE CANNOT BE RESET. SAFECORE IS AN IMPORTANT SAFETY FEATURE THAT THE DEVICE ENTERS AFTER VARIOUS REDUNDANCY CHECKS THAT ARE NOT MATCHED. THERE MIGHT BE AN IMPACT FROM THE DEVICE BEING DROPPED OR EXTENSIVE ELECTROCAUTERY; HOWEVER, THIS CAN ONLY BE CONFIRMED THROUGH ANALYSIS TESTING.

Description of Event or Problem · 1

BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT DURING THE DEVICE REPLACEMENT PROCEDURE; THIS IMPLANTABLE CARDIOVERTER DEFIBRILLATOR WAS IN SAFECORE AND COULD NOT BE INTERROGATED. HOWEVER, DURING THE PROCEDURE THE DEVICE HAD FALLEN DOWN TO THE FLOOR AND PUT INTO A STERILIZER AND AFTER THE STERILIZATION. THE DEVICE WAS PLACED BACK INTO THE PATIENT. A BOSTON SCIENTIFIC CRM TECHNICAL SERVICE CONSULTANT WAS CONTACTED. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 TELIGEN IMPLANTABLE CARDIOVERTER DEFIBRILLATOR LWS GUIDANT CRM CLONMEL IRELAND F110

Patients

Seq Age Sex Outcome Treatment
1 Other